These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36296574)

  • 21. Cyanobiphenyls: Novel H
    Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
    Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis,
    Mo J; Chen T; Yang H; Guo Y; Li Q; Qiao Y; Lin H; Feng F; Liu W; Chen Y; Liu Z; Sun H
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):330-343. PubMed ID: 31856607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation.
    Singh A; Sharma S; Arora S; Attri S; Kaur P; Kaur Gulati H; Bhagat K; Kumar N; Singh H; Vir Singh J; Mohinder Singh Bedi P
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127477. PubMed ID: 32781220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional scutellarin-rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer's disease.
    Sang Z; Li Y; Qiang X; Xiao G; Liu Q; Tan Z; Deng Y
    Bioorg Med Chem; 2015 Feb; 23(4):668-80. PubMed ID: 25614117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geissoschizoline, a promising alkaloid for Alzheimer's disease: Inhibition of human cholinesterases, anti-inflammatory effects and molecular docking.
    Lima JA; R Costa TW; da Fonseca ACC; do Amaral RF; Nascimento MDDSB; Santos-Filho OA; de Miranda ALP; Ferreira Neto DC; Lima FRS; Hamerski L; Tinoco LW
    Bioorg Chem; 2020 Nov; 104():104215. PubMed ID: 32920358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer's Disease.
    Sang Z; Wang K; Han X; Cao M; Tan Z; Liu W
    ACS Chem Neurosci; 2019 Feb; 10(2):1008-1024. PubMed ID: 30537804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang ZP; Qiang XM; Li Y; Wu B; Zhang H; Zhao MG; Deng Y
    Chem Biol Drug Des; 2015 Nov; 86(5):1168-77. PubMed ID: 25941042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease.
    Czarnecka K; Girek M; Maciejewska K; Skibiński R; Jończyk J; Bajda M; Kabziński J; Sołowiej P; Majsterek I; Szymański P
    J Enzyme Inhib Med Chem; 2017 Dec; 33(1):158-170. PubMed ID: 29210299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
    Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
    Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donepezil-ferulic acid hybrids as anti-Alzheimer drugs.
    Benchekroun M; Ismaili L; Pudlo M; Luzet V; Gharbi T; Refouvelet B; Marco-Contelles J
    Future Med Chem; 2015; 7(1):15-21. PubMed ID: 25582330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional 5,6-dimethoxybenzo[d]isothiazol-3(2H)-one-N-alkylbenzylamine derivatives with acetylcholinesterase, monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer's disease.
    Xu R; Xiao G; Li Y; Liu H; Song Q; Zhang X; Yang Z; Zheng Y; Tan Z; Deng Y
    Bioorg Med Chem; 2018 May; 26(8):1885-1895. PubMed ID: 29500132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
    Chen Z; Digiacomo M; Tu Y; Gu Q; Wang S; Yang X; Chu J; Chen Q; Han Y; Chen J; Nesi G; Sestito S; Macchia M; Rapposelli S; Pi R
    Eur J Med Chem; 2017 Jan; 125():784-792. PubMed ID: 27736684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
    Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis.
    Zaib S; Munir R; Younas MT; Kausar N; Ibrar A; Aqsa S; Shahid N; Asif TT; Alsaab HO; Khan I
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, biological evaluation and molecular docking study of novel piperidine and piperazine derivatives as multi-targeted agents to treat Alzheimer's disease.
    Meena P; Nemaysh V; Khatri M; Manral A; Luthra PM; Tiwari M
    Bioorg Med Chem; 2015 Mar; 23(5):1135-48. PubMed ID: 25624107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for treatment of Alzheimer's disease.
    Liu J; Qiu J; Wang M; Wang L; Su L; Gao J; Gu Q; Xu J; Huang SL; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Sep; 1840(9):2886-903. PubMed ID: 24821011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.